Potential significance of colonization with beta-lactamase-producing Haemophilus parainfluenzae in children

Insights

Beta-lactamase-producing Haemophilus parainfluenzae protect other bacteria from ampicillin in lab tests. This suggests these common bacteria may reduce penicillin effectiveness in children.

Area of Science:

  • Microbiology
  • Pharmacology
  • Pediatrics

Background:

  • Healthy children are frequently colonized with beta-lactamase-producing Haemophilus parainfluenzae.
  • These bacteria may inactivate beta-lactam antibiotics, affecting treatment outcomes.
  • The interaction between Haemophilus parainfluenzae and common respiratory pathogens needs investigation.

Purpose of the Study:

  • To investigate the in vitro effect of beta-lactamase-producing Haemophilus parainfluenzae on ampicillin efficacy.
  • To determine if Haemophilus parainfluenzae can protect other bacteria from ampicillin.

Main Methods:

  • Co-culturing beta-lactamase-producing Haemophilus parainfluenzae with ampicillin-sensitive Haemophilus influenzae type b or Streptococcus pyogenes on a membrane.
  • Exposure to ampicillin and observation of bacterial survival.

Main Results:

  • Ampicillin-sensitive strains were killed when tested alone.
  • When co-cultured with beta-lactamase-producing Haemophilus parainfluenzae, susceptible strains were protected from ampicillin.
  • This protection indicates efficient ampicillin degradation by Haemophilus parainfluenzae.

Conclusions:

  • Beta-lactamase-producing Haemophilus parainfluenzae can protect other bacteria from ampicillin in vitro.
  • In vivo, these interactions may alter the effectiveness of beta-lactam antibiotics in the throat.
  • Further research is needed to confirm in vivo implications for antibiotic therapy.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Colonisation of Pathogens01:25

Colonisation of Pathogens

Pathogen colonization of host tissues is a critical step in the development of infectious diseases. Various pathogenic microorganisms, including bacteria, fungi, viruses, and protozoa, have evolved complex strategies to attach to, invade, and persist within host environments. These mechanisms enable pathogens to establish infections, evade immune responses, and resist antimicrobial treatments.Attachment to Host CellsIn bacteria, colonization typically begins with adherence to host epithelial...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...